Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' JANOT F' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fardioni-Laurens, L; Bosq, J; Janot, F; Vayssade, M; Le Bihan, ML; Kaghad, M; Caput, D; Benard, J; Ahomadegbe, JC
      P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

      ONCOGENE
    2. Schwaab, G; Kolb, F; Julieron, M; Janot, F; Le Ridant, AM; Mamelle, G; Marandas, P; Koka, VN; Luboinski, B
      Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974-1997)

      EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
    3. Ribrag, V; Hajj, ME; Janot, F; Girinsky, T; Domenge, C; Schwaab, G; Fenaux, P; Bosq, J
      Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

      LEUKEMIA
    4. De Crevoisier, R; Domenge, C; Wibault, P; Koscielny, S; Lusinchi, A; Janot, F; Bobin, S; Luboinski, B; Eschwege, F; Bourhis, J
      Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

      CANCER
    5. Guerry, M; Vabre, L; Talbot, M; Mamelle, G; Leridant, AM; Hill, C; Bosq, J; Luboinski, B; Janot, F
      Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma - a reply

      BRITISH JOURNAL OF CANCER
    6. Badie, C; Bourhis, J; Sobczak-Thepot, J; Haddada, H; Chiron, M; Janicot, M; Janot, F; Tursz, T; Vassal, G
      p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

      BRITISH JOURNAL OF CANCER
    7. Couteau, C; Chouaki, N; Leyvraz, S; Oulid-Aissa, D; Lebecq, A; Domenge, C; Groult, V; Bordessoule, S; Janot, F; De Forni, M; Armand, JP
      A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

      BRITISH JOURNAL OF CANCER
    8. RIXE O; GATINEAU M; BATOUCHE M; RAYMOND E; DOMENGE C; JANOT F; SCHWAAB G; LUBOINSKI B; ARMAND JP
      SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)

      Annals of oncology
    9. DECREVOISIER R; BOURHIS J; DOMENGE C; WIBAULT P; KOSCIELNY S; LUSINCHI A; MAMELLE G; JANOT F; JULIERON M; LERIDANT AM; MARANDAS P; ARMAND JP; SCHWAAB G; LUBOINSKI B; ESCHWEGE F
      FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS

      Journal of clinical oncology
    10. MASSAADMASSADE L; DOMENGE C; RONGEAT S; HASSOUN L; LEGROS MH; ROPERS J; JANOT F; PARISE O; GOUYETTE A
      RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/

      Anticancer research
    11. KOKA VN; JULIERON M; BOURHIS J; JANOT F; LERIDANT AM; MARANDAS P; LUBOINSKI B; SCHWAAB G
      AESTHESIONEUROBLASTOMA

      Journal of Laryngology and Otology
    12. SALVAN D; JULIERON M; MARANDAS P; JANOT F; LERIDANT AM; DOMENGE C; MAMELLE G; SCHWAAB G; LUBOINSKI B
      COMBINED TRANSFACIAL AND NEUROSURGICAL APPROACH TO MALIGNANT-TUMORS OF THE ETHMOID SINUS

      Journal of Laryngology and Otology
    13. VIEGAS LC; PARISE O; TALBOT M; KOWALSKI LP; LUBOINSKI B; JANOT F; BOSQ J
      LOSS OF C-ERB-B2 EXPRESSION AND TUMOR PROGRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)

      British Journal of Cancer
    14. JANOT F; GUERRY M; VABRE L; TALBOT M; LERIDANT AM; MAMELLE G; HILL C; BOSQ J; LUBOINSKI B
      ABSENCE OF C-ERB-B2 EXPRESSION AND RISK OF DISTANT METASTASIS IN PHARYNGEAL TUMORS

      British Journal of Cancer
    15. DOMENGE C; BATOUCHE M; BELLAMY J; DARTEVELLE P; JANOT F; MARANDAS P; LUBOINSKI B
      RESECTION OF LUNG NEOPLASTIC NODULES LONG-TERM BENEFIT SURVIVAL FROM HEAD AND NECK-CANCER PATIENTS

      British Journal of Cancer
    16. Guerry, M; Vabre, L; Talbot, M; Mamelle, G; Leridant, AM; Hill, C; Bosq, J; Luboinski, B; Janot, F
      Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study

      BRITISH JOURNAL OF CANCER
    17. FORTIN A; GUERRY M; GUERRY R; TALBOT M; PARISE O; SCHWAAB G; BOSQ J; BOURHIS J; SALVATORI P; JANOT F; BUSSON P
      CHROMOSOME 11Q13 GENE AMPLIFICATIONS IN ORAL AND OROPHARYNGEAL CARCINOMAS - NO CORRELATION WITH SUBCLINICAL LYMPH-NODE INVASION AND DISEASERECURRENCE

      Clinical cancer research
    18. SCHWAAB G; JULIERON M; JANOT F
      EPIDEMIOLOGY OF UPPER AERODIGESTIVE TRACT CANCER

      Neuro-chirurgie
    19. CLAYMAN GL; LIU TJ; OVERHOLT SM; MOBLEY SR; WANG M; JANOT F; GOEPFERT H
      GENE-THERAPY FOR HEAD AND NECK-CANCER - COMPARING THE TUMOR-SUPPRESSOR GENE P53 AND A CELL-CYCLE REGULATOR WAF1 CIP1 (P21)/

      Archives of otolaryngology, head & neck surgery
    20. WIBAULT P; BENSMAINE MEA; DEFORNI M; ARMAND JP; BERNAL ET; GUILLOT T; RECONDO G; DOMENGE C; JANOT F; BOREL C; LUBOINSKI B; ESCHWEGE F; CVITKOVIC E
      INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL

      Journal of clinical oncology
    21. BOURHIS J; DENDALE R; HILL C; BOSQ J; JANOT F; ATTAL P; FORTIN A; MARANDAS P; SCHWAAB G; WIBAULT P; MALAISE EP; BOBIN S; LUBOINSKI B; ESCHWEGE F; WILSON G
      POTENTIAL DOUBLING TIME AND CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA TREATED WITH 70 GY IN 7 WEEKS

      International journal of radiation oncology, biology, physics
    22. BENSMAINE MEA; GUILLOT T; BERNAL ET; JANOT F; SIGAL R; DOMENGE C; WIBAULT P; ARMAND JP; CVITKOVIC E
      NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN-VINDESINE-5-FLUOSOURACIL AND FOLINIC ACID FOR LOCALLY ADVANCED HEAD AND NECK-CARCINOMA

      American journal of clinical oncology
    23. JANOT F; KLIJANIENKO J; RUSSO A; MAMET JP; DEBRAUD F; ELNAGGAR AK; PIGNON JP; LUBOINSKI B; CVITKOVIC E
      PROGNOSTIC VALUE OF CLINICOPATHOLOGICAL PARAMETERS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PROSPECTIVE ANALYSIS

      British Journal of Cancer
    24. RIBRAG V; MASSAAD L; JANOT F; MORIZET J; GOUYETTE A; CHABOT GG
      MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY

      Leukemia & lymphoma
    25. DOMENGE C; MASSADE L; RONGEAT S; HASSOUN L; LEGROS MH; JANOT F; JULIERON M; LUBOINSKI B; GOUYETTE A
      GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY

      European journal of cancer
    26. JANOT F; ELNAGGAR AK; MORRISON RS; LIU TJ; TAYLOR DL; CLAYMAN GL
      EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK IS ASSOCIATED WITH DEGREE OF HISTOLOGIC DIFFERENTIATION

      International journal of cancer
    27. KLIJANIENKO J; ELNAGGAR AK; DEBRAUD F; RODRIGUEZPERALTO JL; RODRIGUEZ R; ITZHAKI M; RUSSO A; JANOT F; LUBOINSKI B; CVITKOVIC E
      TUMOR VASCULARIZATION, MITOTIC INDEX, HISTOPATHOLOGIC GRADE, AND DNA-PLOIDY IN THE ASSESSMENT OF 114 HEAD AND NECK SQUAMOUS-CELL CARCINOMAS

      Cancer
    28. PARISE O; JANOT F; LUBOINSKI B; MASSAAD L; ALBIN N; TOUSSAINT C; VERJUS MA; BONNAY M; GOUYETTE A; CHABOT GG
      THYMIDYLATE SYNTHASE ACTIVITY, FOLATES, AND GLUTATHIONE SYSTEM IN HEAD AND NECK-CARCINOMA AND ADJACENT TISSUES

      Head & neck
    29. PARISE O; JANOT F; GUERRY R; FORTIN A; LUBOINSKI B; TURSZ T; SCHWAAB G; BUSSON P
      CHROMOSOME-11Q13 GENE AMPLIFICATIONS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - RELATION WITH LYMPH-NODE INVASION

      International journal of oncology
    30. GIRINSKY T; BERNHEIM A; LUBIN R; TAVAKOLIRAZAVI T; BAKER F; JANOT F; WIBAULT P; COSSET JM; DUVILLARD P; DUVERGER A; FERTIL B
      IN-VITRO PARAMETERS AND TREATMENT OUTCOME IN HEAD AND NECK CANCERS TREATED WITH SURGERY AND OR RADIATION - CELL CHARACTERIZATION AND CORRELATIONS WITH LOCAL-CONTROL AND OVERALL SURVIVAL/

      International journal of radiation oncology, biology, physics
    31. RIBRAG V; MASSAAD L; JANOT F; BISSERY MC; PARISE O; GOUYETTE A; CHABOT GG
      PRINCIPAL DRUG-METABOLIZING ENZYME-SYSTEMS IN L1210 LEUKEMIA SENSITIVE OR RESISTANT TO BCNU IN-VIVO

      Leukemia research
    32. ROUX FX; BRASNU D; DEVAUX B; CHABARDES E; SCHWAAB G; LACCOURREYE O; MENARD M; JANOT F; NGUYEN S; BERTRAND J; MEDER JF
      ETHMOID SINUS CARCINOMAS - RESULTS AND PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY AND COMBINED SURGERY - A 10-YEAR EXPERIENCE

      Surgical neurology
    33. BOURHIS J; WILSON G; WIBAULT P; BOSQ J; ARMAND JP; LUBOINSKI B; MALAISE EP; ESCHWEGE F; JANOT F
      RAPID TUMOR-CELL PROLIFERATION AFTER INDUCTION CHEMOTHERAPY IN OROPHARYNGEAL CANCER

      The Laryngoscope
    34. JANOT F; CVITKOVIC E; PIEKARSKI JD; SIGAL R; ARMAND JP; BENSMAINE A; LUBOINSKI B
      CORRELATION BETWEEN NODAL DENSITY IN CONTRASTED SCANS AND RESPONSE TOCISPLATIN-BASED CHEMOTHERAPY IN HEAD AND NECK SQUAMOUS-CELL CANCER - A PROSPECTIVE VALIDATION

      Head & neck
    35. JANOT F; STRAZIELLE C; DASILVA MAP; CUSSENOT O
      ADAPTATION OF FACIAL ARCHITECTURE IN THE TOULOUSE DEFORMITY (23.10.92)

      Surgical and radiologic anatomy
    36. KLIJANIENKO J; ELNAGGAR A; DEBRAUD F; MICHEAU C; JANOT F; LUBOINSKI B; GENTILE A; RUSSO A; CVITKOVIC E
      KERATIN-6, KERATIN-13 AND KERATIN-19 - DIFFERENTIAL EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Analytical and quantitative cytology and histology
    37. BOURHIS J; WILSON G; WIBAULT P; BOSQ J; CHAVAUDRA N; JANOT F; LUBOINSKI B; ESCHWEGE F; MALAISE EP
      IN-VIVO MEASUREMENT OF THE POTENTIAL DOUBLING TIME BY FLOW-CYTOMETRICIN OROPHARYNGEAL CANCER TREATED BY CONVENTIONAL RADIOTHERAPY

      International journal of radiation oncology, biology, physics
    38. JANOT F; MASSAAD L; RIBRAG V; DEWAZIERS I; BEAUNE PH; LUBOINSKI B; PARISE O; GOUYETTE A; CHABOT GG
      PRINCIPAL XENOBIOTIC-METABOLIZING ENZYME-SYSTEMS IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Carcinogenesis
    39. MASSAAD L; DEWAZIERS I; RIBRAG V; JANOT F; MORIZET J; BEAUNE PH; GOUYETTE A; CHABOT GG
      SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS

      Bulletin du cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 12:52:21